APTEVO THERAPEUTICS INC (APVO)
US03835L3069 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.309M | 12.292M 185.26% | 3.114M -74.67% | -100.00% | 3.85M | 59.098M 1,435.01% | 80.539M 36.28% | 92.3M 14.60% | 95.498M 3.46% | |||
| EBITDA YoY % growth | -26.088M 32.64% | -20.256M 22.36% | -27.74M -36.95% | N/A -2.06% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -27.494M 32.88% | -21.4M 22.16% | -28.641M -33.84% | -29.808M -0.83% | -24.958M 13.57% | -23.663M 5.19% | -25.977M -9.78% | 37.065M 242.68% | 58.151M 56.89% | 70.098M 20.54% | 73.476M 4.82% | |
| Operating Margin | -638.06% | -174.10% | -919.75% | N/A | N/A | N/A | -674.72% | 62.72% | 72.20% | 75.95% | 76.94% | |
| EPS YoY % growth | -394.24 43.86% | -267.96 32.03% | 69.52 125.94% | -2,847.86 -193.67% | -646.67 -893.05% | -217.57 66.36% | -143.79 33.91% | 23.02 116.01% | 27.93 21.31% | 33.21 18.92% | 33.97 2.27% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -3.21 47.84% | -0.29 97.13% | -0.26 84.73% | -0.26 46.87% | -0.26 92.06% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.322M 16.63% | -5.327M 23.71% | -5.333M 25.51% | -5.339M 13.54% | -5.344M -0.40% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.48 97.82% | -3.42 | 2.94 | 85.97% |
| Q2 2024 Q2Q % growth | -1.67 96.91% | -6.68 | 5.01 | 75.00% |
| Q1 2024 Q2Q % growth | -9.95 -157.98% | -13.10 | 3.15 | 24.06% |
| Q4 2023 Q2Q % growth | -6.16 85.26% | -18.40 | 12.24 | 66.52% |
| Q3 2023 Q2Q % growth | -22.00 66.67% | -33.66 | 11.66 | 34.64% |
| Q2 2023 Q2Q % growth | -54.12 -122.04% | -50.27 | -3.85 | -7.67% |
| Q1 2023 Q2Q % growth | 17.16 125.16% | -53.18 | 70.34 | 132.27% |
| Q4 2022 Q2Q % growth | -41.80 25.20% | -68.67 | 26.87 | 39.13% |
| Q3 2022 Q2Q % growth | -66.00 -4.90% | -73.60 | 7.60 | 10.33% |
| Q2 2022 Q2Q % growth | 245.52 418.86% | -59.69 | 305.21 | 511.32% |
| Q1 2022 Q2Q % growth | -68.20 5.49% | -51.61 | -16.59 | -32.14% |
| Q4 2021 Q2Q % growth | -55.88 33.85% | -58.12 | 2.24 | 3.85% |
| Q3 2021 Q2Q % growth | -62.92 31.90% | -66.20 | 3.28 | 4.95% |
| Q2 2021 Q2Q % growth | -77.00 16.67% | -89.76 | 12.76 | 14.22% |
| Q1 2021 Q2Q % growth | -72.16 42.25% | 75.85 | -148.01 | -195.14% |
| Q4 2020 Q2Q % growth | -84.48 19.33% | -54.53 | -29.95 | -54.93% |
| Q3 2020 Q2Q % growth | -92.40 34.78% | -90.43 | -1.97 | -2.17% |
| Q2 2020 Q2Q % growth | -92.40 50.00% | -92.23 | -0.17 | -0.19% |
| Q1 2020 Q2Q % growth | -124.96 53.90% | -105.47 | -19.49 | -18.48% |
| Q4 2019 Q2Q % growth | -104.72 | -161.27 | 56.55 | 35.07% |
| Q3 2019 Q2Q % growth | -141.68 | -150.80 | 9.12 | 6.05% |
| Q2 2019 Q2Q % growth | -184.80 | -207.35 | 22.55 | 10.87% |
| Q1 2019 Q2Q % growth | -271.04 | -276.46 | 5.42 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | 3.494M | -3.494M | -100.00% |
| Q1 2022 Q2Q % growth | 3.114M 28.62% | 3.825M | -711K | -18.59% |
| Q4 2021 Q2Q % growth | 3.665M 54.45% | 3.468M | 197K | 5.68% |
| Q3 2021 Q2Q % growth | 3.096M 111.62% | 3.723M | -627K | -16.84% |
| Q2 2021 Q2Q % growth | 3.11M 557.51% | 918K | 2.192M | 238.78% |
| Q1 2021 Q2Q % growth | 2.421M | 13.328M | -10.907M | -81.84% |
| Q4 2020 Q2Q % growth | 2.373M | 1.78M | 593K | 33.31% |
| Q3 2020 Q2Q % growth | 1.463M | 574.943K | 888.057K | 154.46% |
| Q2 2020 Q2Q % growth | 473K | 266.903K | 206.097K | 77.22% |
| Q1 2020 Q2Q % growth | 5.272M | -5.272M | -100.00% | |
| Q4 2019 Q2Q % growth | 9.609M | -9.609M | -100.00% | |
| Q3 2019 Q2Q % growth | 9.18M | -9.18M | -100.00% | |
| Q2 2019 Q2Q % growth | 7.185M | -7.185M | -100.00% | |
| Q1 2019 Q2Q % growth | 6.903M | -6.903M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -3600% | -3441.87% |
| Revenue | N/A | N/A | N/A | N/A |